H. Riethmüller-Winzen

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

Carola Albano, R. Felberbaum, Johan Smitz et al. · Human Reproduction · 2000 · 312 citations · Full text

Veterinary Medicine, Endocrinology, Gynecology +13

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

Carola Albano, Johan Smitz, Michel Camus et al. · Fertility and Sterility · 1997 · 243 citations · Full text

Medicine, Endocrinology, Gynecology +11

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

Róbert Hermann, G Niebch, Harald O. Borbe et al. · European Journal of Pharmaceutical Sciences · 1996 · 111 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix

Carola Albano, Grigoris Grimbizis, Johan Smitz et al. · Fertility and Sterility · 1998 · 110 citations

Medicine, Endocrinology, Gynecology +17

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction

Mirna Stela Ludwig, R. Felberbaum, Paul Devroey et al. · Archives of Gynecology and Obstetrics · 2000 · 96 citations

Medicine, Endocrinology, Gynecology +10